Indonesia
· Delayed Price · Currency is IDR PT Pyridam Farma Tbk Statistics
Total Valuation
PT Pyridam Farma Tbk has a market cap or net worth of IDR 1.57 trillion. The enterprise value is 2.47 trillion.
| Market Cap | 1.57T |
| Enterprise Value | 2.47T |
Important Dates
The next estimated earnings date is Friday, November 1, 2024.
| Earnings Date | Nov 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PT Pyridam Farma Tbk has 11.24 billion shares outstanding.
| Shares Outstanding | 11.24B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | n/a |
| Float | 4.40B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.11 |
| PB Ratio | 0.21 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 41.41, with an EV/FCF ratio of -21.05.
| EV / Earnings | -28.99 |
| EV / Sales | 3.52 |
| EV / EBITDA | 41.41 |
| EV / EBIT | n/a |
| EV / FCF | -21.05 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 276.42.
| Current Ratio | 1.94 |
| Quick Ratio | 0.98 |
| Debt / Equity | 276.42 |
| Debt / EBITDA | 16.54 |
| Debt / FCF | -8.41 |
| Interest Coverage | 0.02 |
Financial Efficiency
Return on equity (ROE) is -21.32% and return on invested capital (ROIC) is 0.08%.
| Return on Equity (ROE) | -21.32% |
| Return on Assets (ROA) | 0.07% |
| Return on Capital (ROIC) | 0.08% |
| Revenue Per Employee | 588.49M |
| Profits Per Employee | -71.43M |
| Employee Count | 1,193 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.87 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +248.27% in the last 52 weeks. The beta is 0.81, so PT Pyridam Farma Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +248.27% |
| 50-Day Moving Average | 105.12 |
| 200-Day Moving Average | 73.72 |
| Relative Strength Index (RSI) | 64.57 |
| Average Volume (20 Days) | 46,934,675 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Pyridam Farma Tbk had revenue of IDR 702.07 billion and -85.22 billion in losses. Loss per share was -159.27.
| Revenue | 702.07B |
| Gross Profit | 295.32B |
| Operating Income | 1.76B |
| Pretax Income | -83.25B |
| Net Income | -85.22B |
| EBITDA | 53.95B |
| EBIT | 1.76B |
| Loss Per Share | -159.27 |
Balance Sheet
The company has 89.97 billion in cash and 986.99 billion in debt, giving a net cash position of -897.02 billion or -79.83 per share.
| Cash & Cash Equivalents | 89.97B |
| Total Debt | 986.99B |
| Net Cash | -897.02B |
| Net Cash Per Share | -79.83 |
| Equity (Book Value) | 357.06B |
| Book Value Per Share | 666.88 |
| Working Capital | 276.82B |
Cash Flow
In the last 12 months, operating cash flow was -103.98 billion and capital expenditures -13.36 billion, giving a free cash flow of -117.35 billion.
| Operating Cash Flow | -103.98B |
| Capital Expenditures | -13.36B |
| Free Cash Flow | -117.35B |
| FCF Per Share | -10.44 |
Margins
Gross margin is 42.06%, with operating and profit margins of 0.25% and -12.14%.
| Gross Margin | 42.06% |
| Operating Margin | 0.25% |
| Pretax Margin | -11.86% |
| Profit Margin | -12.14% |
| EBITDA Margin | 7.68% |
| EBIT Margin | 0.25% |
| FCF Margin | -16.71% |
Dividends & Yields
PT Pyridam Farma Tbk does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -113.76% |
| FCF Yield | -7.46% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |